Photo by charlesdeluvio from unsplash
: Conflict of interest: COI declared - see note COI notes: Y.B. is a member of the French advisory boards for Sanofi and Takeda. A.V. is a member of the… Click to show full abstract
: Conflict of interest: COI declared - see note COI notes: Y.B. is a member of the French advisory boards for Sanofi and Takeda. A.V. is a member of the French advisory boards for Sanofi, Takeda, and Roche-Chugai. P.C. is a member of advisory boards for and received speaker fees from Sanofi, Alexion, Octapharma, and Takeda. The remaining authors declare no competing financial interests. Preprint Author contributions and disclosures: A.P. and P.C wrote the first draft of the manuscript. P.C and R.B. analyzed the data of the French cohort. All authors critically reviewed and made substantial contributions to the manuscript. Non-author contributions and disclosures: No; Agreement to Share Publication-Related Data and Data Sharing Statement: email to corresponding author (P.C.)
Journal Title: Blood advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!